Editorial
Emmanouil Petrou
Abstract
Heart disease and cancer are currently the two leading causes of death in the Western World, creating an intriguing scenario when these two diseases intersect. It is increasingly being recognized that cancer therapeutics have unintended cardiovascular toxicity. Cardio-oncology is a novel, interdisciplinary area of growing interest, based on a comprehensive approach for the management of cancer patients with cardiac diseases.